Calpain 1 Antibody (CAPN1/1530) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08456DL594
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # CAPN1/1530
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant full-length human Calpain 1 protein (Uniprot: P07384)
Localization
Cytoplasm and Cell Surface
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for Calpain 1 Antibody (CAPN1/1530) [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Calpain 1
Long Name
Calpain-1 catalytic subunit
Alternate Names
Calpain mu-type, CANP 1, CANPL1, CAPN1, EC 3.4.22.52, Micromolar-calpain, muCANP, PIG30
Gene Symbol
CAPN1
Additional Calpain 1 Products
Product Documents for Calpain 1 Antibody (CAPN1/1530) [DyLight 594]
Product Specific Notices for Calpain 1 Antibody (CAPN1/1530) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...